SANUWAVE Health, Inc. is a shockwave technology company, which engages in the development and commercialization of patented noninvasive, biological response activating devices. The company is headquartered in Eden Prairie, Minnesota and currently employs 46 full-time employees. The company went IPO on 2008-11-07. The company is a provider of wound care products. The company is focused on the research, development, and commercialization of its patented, non-invasive, and biological response-activating medical systems for the repair and regeneration of skin, musculoskeletal tissue, and vascular structures. The company applies and researches its patented energy transfer technologies in wound healing, orthopedic/spine, and aesthetic/cosmetic. Its two primary systems are UltraMIST and PACE. The UltraMIST system provides, through a fluid mist, low-frequency, non-contact, and pain free ultrasound energy deep inside the wound bed that promotes healing. The PACE systems use acoustic pressure shockwaves generated by the Company's Pulsed Acoustic Cellular Expression technology to converge at precise selected targets to produce short duration compression burst and are used in both wound and orthopedic applications under the brand names dermaPACE and others.
최신 재무제표(Form-10K)에 따르면, SANUWAVE Health Inc의 총 자산은 $0이며, 순손실입니다.
SNWV의 주요 재무 비율은 무엇인가요?
SANUWAVE Health Inc의 유동비율은 0이고, 순이익률은 0, 주당 매출은 $0입니다.
SANUWAVE Health Inc의 매출은 부문 또는 지역별로 어떻게 나뉘나요?
SANUWAVE Health Inc 주요 수익원은 Consumable and Parts이며, 최신 수익 발표에서 수익은 13,222,000입니다. 지역별로는 United States이 SANUWAVE Health Inc의 주요 시장이며, 수익은 20,168,000입니다.